Physician profile
Manoj Kumar
NPI 1730371196
$5,431.21
in general payments reported to CMS, 2019-2025
18 companies · $884 in 2025
The $884 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,401 · 2020: $28.57 · 2021: $1,370 · 2022: $1,059 · 2023: $605 · 2024: $83.70 · 2025: $884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,028 · Food and Beverage: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,028.35 |
| Food and Beverage | $544.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $2,715.10 | 2021-2025 | Single Use Electrosurgical Knife Kd-655, Olympus, Disposable Distal Attachment |
| Endogastric Solutions, INC | $1,282.17 | 2019 | |
| Boston Scientific Corporation | $515.13 | 2021-2025 | Advanix Biliary, X-Tack Endoscopic Helix Tacking System, Expect |
| Medtronic, INC. | $144.76 | 2021-2024 | Interstim |
| Olympus America INC. | $123.61 | 2019-2025 | Endoclot Phs, Gastrointestinal Videoscope |
| Abbvie INC. | $83.10 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $80.17 | 2022-2025 | Entyvio, Eohilia |
| Cook Medical LLC | $72.67 | 2020-2021 | |
| Steris Corporation | $67.58 | 2021 | |
| Janssen Biotech, INC. | $63.83 | 2025 | Tremfya |
| Covidien Lp | $63.70 | 2019 | |
| Erbe USA INC | $61.22 | 2022 | |
| Lumendi LLC | $45.75 | 2021 | |
| Ardelyx, INC. | $31.56 | 2025 | Ibsrela |
| Genzyme Corporation | $27.32 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $24.02 | 2025 | Wegovy |
| Beigene USA, INC. | $15.75 | 2024 | Brukinsa |
| Genentech USA, INC. | $13.77 | 2023 | Venclexta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manoj Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.